NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0115-5213-02 | 0115-5213 | HUMAN PRESCRIPTION DRUG | COLESTIPOL HYDROCHLORIDE | COLESTIPOL HYDROCHLORIDE | SUSPENSION | ORAL | 20060502 | N/A | ANDA | ANDA077277 | Amneal Pharmaceuticals of New York LLC | COLESTIPOL HYDROCHLORIDE | 5 g/1 | 100 SUSPENSION in 1 BOTTLE (0115-5213-02) |
0115-5212-29 | 0115-5212 | HUMAN PRESCRIPTION DRUG | COLESTIPOL HYDROCHLORIDE | COLESTIPOL HYDROCHLORIDE | SUSPENSION | ORAL | 20060502 | N/A | ANDA | ANDA077277 | Amneal Pharmaceuticals of New York LLC | COLESTIPOL HYDROCHLORIDE | 5 g/1 | 90 SUSPENSION in 1 CARTON (0115-5212-29) |
0115-5212-18 | 0115-5212 | HUMAN PRESCRIPTION DRUG | COLESTIPOL HYDROCHLORIDE | COLESTIPOL HYDROCHLORIDE | SUSPENSION | ORAL | 20060502 | N/A | ANDA | ANDA077277 | Amneal Pharmaceuticals of New York LLC | COLESTIPOL HYDROCHLORIDE | 5 g/1 | 30 SUSPENSION in 1 CARTON (0115-5212-18) |